{"id":"iv-iron-standard-of-care","safety":{"commonSideEffects":[{"rate":"5-15","effect":"Injection site reactions (pain, discoloration)"},{"rate":"5-10","effect":"Headache"},{"rate":"3-8","effect":"Nausea"},{"rate":"0.5-2","effect":"Hypersensitivity reactions"},{"rate":"2-5","effect":"Dizziness"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Intravenous iron formulations bypass gastrointestinal absorption limitations and rapidly restore systemic iron levels in patients with iron deficiency anemia. The iron is transported to bone marrow erythroid precursors and other tissues where it is incorporated into hemoglobin, myoglobin, and iron-dependent enzymes, restoring oxygen-carrying capacity and metabolic function.","oneSentence":"IV iron replenishes depleted iron stores by delivering iron directly into the bloodstream for incorporation into hemoglobin and other iron-dependent proteins.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:48:22.025Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Iron deficiency anemia in patients intolerant of or unresponsive to oral iron"},{"name":"Iron deficiency anemia in chronic kidney disease patients on hemodialysis"},{"name":"Perioperative iron replacement"}]},"trialDetails":[{"nctId":"NCT07476859","phase":"PHASE4","title":"Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome","status":"RECRUITING","sponsor":"Fundación para la Investigación del Hospital Clínico de Valencia","startDate":"2026-03-05","conditions":"Acute Coronary Syndromes (ACS), Iron Deficiencies, Elderly (People Aged 65 or More)","enrollment":538},{"nctId":"NCT07461948","phase":"PHASE3","title":"Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients","status":"RECRUITING","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2025-10-27","conditions":"Glioblastoma","enrollment":15},{"nctId":"NCT06287619","phase":"PHASE2","title":"Post-operative Intravenous Iron to Treat Iron-deficiency Anemia in Patients Undergoing Cardiac Surgery","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2025-04-03","conditions":"Chronic Iron Deficiency Anaemia, Cardiac Surgery","enrollment":60},{"nctId":"NCT05340465","phase":"PHASE2","title":"Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants","status":"RECRUITING","sponsor":"University of Washington","startDate":"2022-11-27","conditions":"Prematurity, Iron-deficiency, Iron Deficiency Anemia","enrollment":120},{"nctId":"NCT05753215","phase":"PHASE2","title":"Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection","status":"ACTIVE_NOT_RECRUITING","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2023-05-09","conditions":"Bone Infection, Joint Infection, Bone and Joint Infection","enrollment":180},{"nctId":"NCT07287371","phase":"PHASE4","title":"Sucrosomial Vs Intravenous Iron for Preoperative Anemia","status":"NOT_YET_RECRUITING","sponsor":"University of Rochester","startDate":"2025-12-31","conditions":"Anemia, Iron Deficiency Anemia","enrollment":75},{"nctId":"NCT07197905","phase":"PHASE2","title":"Restoring Iron Deficiency in POTS","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2025-11-24","conditions":"POTS - Postural Orthostatic Tachycardia Syndrome","enrollment":12},{"nctId":"NCT04900792","phase":"PHASE1","title":"A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bryan Allen","startDate":"2023-02-28","conditions":"Glioblastoma, Glioblastoma Multiforme","enrollment":17},{"nctId":"NCT07083583","phase":"","title":"Impact of IV Iron on Bleeding Symptoms in Iron Deficient Patients With Inherited Bleeding Disorders","status":"RECRUITING","sponsor":"Nicoletta C Machin","startDate":"2025-08-08","conditions":"Bleeding Disorders, Iron, Platelet","enrollment":40},{"nctId":"NCT03347617","phase":"PHASE2","title":"Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma","status":"TERMINATED","sponsor":"OHSU Knight Cancer Institute","startDate":"2017-12-20","conditions":"Glioblastoma","enrollment":52},{"nctId":"NCT06508827","phase":"PHASE2","title":"Intravenous Iron in Combination With Standard of Care Immunotherapy in Melanoma","status":"WITHDRAWN","sponsor":"Indiana University","startDate":"2025-05","conditions":"Anemia, Iron Deficiency, Melanoma","enrollment":""},{"nctId":"NCT01950247","phase":"PHASE4","title":"Evaluate the Utility of Serum Hepcidin Levels to Predict Response to Oral or IV Iron","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2013-08-15","conditions":"Iron Deficiency Anemia (IDA)","enrollment":1025},{"nctId":"NCT05167734","phase":"PHASE2","title":"Practical Anemia Bundle for SusTained Blood Recovery","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2021-11-30","conditions":"Anemia, Critical Illness","enrollment":100},{"nctId":"NCT02278341","phase":"PHASE3","title":"Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable Dialysis","status":"COMPLETED","sponsor":"Astellas Pharma Europe B.V.","startDate":"2014-11-21","conditions":"Anemia, End Stage Renal Disease (ESRD)","enrollment":838},{"nctId":"NCT06703411","phase":"PHASE4","title":"Intravenous Iron Sucrose for Acute Decompensated Heart Failure Patients With Reduced Ejection Fraction and Iron Deficiency","status":"COMPLETED","sponsor":"Cheng-Hsin General Hospital","startDate":"2023-05-01","conditions":"Heart Failure With Reduced Ejection Fraction (HFrEF), Hospitalization, Iron Deficiency","enrollment":76},{"nctId":"NCT02021318","phase":"PHASE3","title":"Roxadustat in the Treatment of Anemia in Chronic Kidney Disease (CKD) Patients, Not on Dialysis, in Comparison to Darbepoetin Alfa","status":"COMPLETED","sponsor":"Astellas Pharma Europe B.V.","startDate":"2014-03-12","conditions":"Anemia in Chronic Kidney Disease in Non-dialysis Patients","enrollment":616},{"nctId":"NCT05929729","phase":"PHASE4","title":"Iron Deficiency Anemia (IDA) and the Brain","status":"RECRUITING","sponsor":"Children's Hospital Los Angeles","startDate":"2023-12-07","conditions":"IDA - Iron Deficiency Anemia, Anemia, Iron Deficiency Anemia","enrollment":120},{"nctId":"NCT02889133","phase":"NA","title":"Donor Iron Deficiency Study - Red Blood Cells From Iron-deficient Donors: Recovery and Storage Quality","status":"COMPLETED","sponsor":"Columbia University","startDate":"2017-01","conditions":"Iron Deficiency","enrollment":79},{"nctId":"NCT05358509","phase":"PHASE4","title":"Reducing Anemia in Pregnancy in India: the RAPIDIRON Trial","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2021-03-15","conditions":"Iron Deficiency Anemia, Infant, Low Birth Weight, Anemia of Pregnancy","enrollment":4368},{"nctId":"NCT01336803","phase":"PHASE2","title":"Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI","status":"COMPLETED","sponsor":"Heike E Daldrup-Link","startDate":"2011-08","conditions":"Bone Cancer, Chondrosarcoma, Ewing's Sarcoma","enrollment":32},{"nctId":"NCT05708170","phase":"PHASE4","title":"Impact of Intravenous Iron on Musculoskeletal Function in Older Adults","status":"NOT_YET_RECRUITING","sponsor":"Liverpool Hope University","startDate":"2023-01","conditions":"Iron Deficiency Anemia","enrollment":100},{"nctId":"NCT04922645","phase":"PHASE4","title":"Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants","status":"COMPLETED","sponsor":"USRC Kidney Research","startDate":"2021-06-29","conditions":"Hyperphosphatemia, Anemia, Iron Deficiency, Renal Insufficiency","enrollment":214},{"nctId":"NCT02642562","phase":"PHASE4","title":"Intravenous Iron Treatment in Patients With Heart Failure and Iron Deficiency: IRONMAN","status":"COMPLETED","sponsor":"University of Glasgow","startDate":"2016-08","conditions":"Chronic Heart Failure, Iron Deficiency, Left Ventricular Systolic Dysfunction","enrollment":1160},{"nctId":"NCT01147666","phase":"PHASE2","title":"Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance Hemodialysis","status":"COMPLETED","sponsor":"Kyntra Bio","startDate":"2010-05-17","conditions":"End Stage Renal Disease, Anemia","enrollment":161},{"nctId":"NCT03234309","phase":"PHASE2","title":"Ferumoxytol in Magnetic Resonance Imaging of Pediatric Patients With Brain Tumors","status":"WITHDRAWN","sponsor":"OHSU Knight Cancer Institute","startDate":"2017-10-20","conditions":"Brain Neoplasm","enrollment":""},{"nctId":"NCT04668469","phase":"NA","title":"Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic","status":"COMPLETED","sponsor":"Benha University","startDate":"2020-06-08","conditions":"Covid19","enrollment":600},{"nctId":"NCT03888768","phase":"NA","title":"ProPBM : A Modified Patient Blood Management Protocol","status":"UNKNOWN","sponsor":"Ministry of Health, Malaysia","startDate":"2019-08-01","conditions":"Iron-deficiency","enrollment":180},{"nctId":"NCT02504294","phase":"PHASE3","title":"A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis","status":"COMPLETED","sponsor":"Pfizer","startDate":"2015-07-13","conditions":"Chronic Kidney Disease (CKD)","enrollment":432},{"nctId":"NCT00481624","phase":"PHASE2","title":"Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia","status":"WITHDRAWN","sponsor":"University of Louisville","startDate":"2007-05","conditions":"Anemia","enrollment":""},{"nctId":"NCT03042130","phase":"PHASE4","title":"Treatment With IV Iron in Hospitalized Patients With Severe Heart Failure But Without Iron Deficiency","status":"WITHDRAWN","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2016-12-14","conditions":"Heart Failure","enrollment":""},{"nctId":"NCT00982007","phase":"PHASE3","title":"Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA)","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2009-09","conditions":"Iron Deficiency Anemia","enrollment":997},{"nctId":"NCT00548691","phase":"PHASE3","title":"Safety and Tolerability of FCM vs Standard of Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease Patients","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2007-10","conditions":"Anemia","enrollment":513},{"nctId":"NCT00548860","phase":"PHASE3","title":"Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2007-10","conditions":"Anemia","enrollment":2018},{"nctId":"NCT02905708","phase":"NA","title":"Efficacy of Warming Garment in the Perioperative Period With Integrated Chemical Heat Packs to Maintain Normothermia","status":"COMPLETED","sponsor":"Dr K Services PC","startDate":"2016-12-01","conditions":"Hypothermia","enrollment":48},{"nctId":"NCT00129259","phase":"PHASE2","title":"Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2005-09","conditions":"Diabetes Mellitus, Type 1","enrollment":83},{"nctId":"NCT01394562","phase":"PHASE3","title":"Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure","status":"COMPLETED","sponsor":"Vifor Pharma","startDate":"2011-07","conditions":"Iron Deficiency, Chronic Heart Failure","enrollment":174},{"nctId":"NCT00224081","phase":"PHASE4","title":"DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)","status":"COMPLETED","sponsor":"Watson Pharmaceuticals","startDate":"2004-09","conditions":"Anemia, Iron-Deficiency, Kidney Failure, Chronic, Hemodialysis","enrollment":134},{"nctId":"NCT02385383","phase":"","title":"An Intravenous Iron Based Protocol for Preoperative Anaemia in Hip and Knee Surgery - An Observational Study","status":"UNKNOWN","sponsor":"Rigshospitalet, Denmark","startDate":"2014-10","conditions":"Anemia, Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee","enrollment":300},{"nctId":"NCT00803634","phase":"PHASE3","title":"Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure (PRONTO)","status":"COMPLETED","sponsor":"The Medicines Company","startDate":"2008-12","conditions":"Hypertension, Heart Failure","enrollment":117}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":17,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"IV Iron (standard of care)","genericName":"IV Iron (standard of care)","companyName":"Nicoletta C Machin","companyId":"nicoletta-c-machin","modality":"Small molecule","firstApprovalDate":"","aiSummary":"IV iron replenishes depleted iron stores by delivering iron directly into the bloodstream for incorporation into hemoglobin and other iron-dependent proteins. Used for Iron deficiency anemia in patients intolerant of or unresponsive to oral iron, Iron deficiency anemia in chronic kidney disease patients on hemodialysis, Perioperative iron replacement.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}